| Literature DB >> 31879489 |
Tetsutaro Abe1, Nobuhiro Kaku1, Tomonori Tabata1, Hiroaki Tagomori1, Hiroshi Tsumura1.
Abstract
We aimed to clarify the possibility of using bipolar hip arthroplasty (BHA) for degenerative diseases by examining long-term results postoperatively in 336 hips. Patients' average age was 61.0 years (range, 34-88 years), and the average follow-up period was 12.5 years (range, 5.0-27.3 years). The 5-year, 10-year, and 20-year Kaplan Meier survival rates (end point: revision) were 92.1%, 81.8%, and 20.1% in the osteoarthritis group and 96.4%, 90.1%, and 24.6% in the rheumatoid arthritis group, respectively. Since the survival rate for more than 10 years decreases rapidly, the use of BHA for treating degenerative diseases should be restricted.Entities:
Keywords: BHA, bipolar head arthroplasty; Bipolar hemiarthroplasty; CE, cup-center-edge; Migration; OA, osteoarthritis; Osteoarthritis; RA, rheumatoid arthritis; Rheumatoid arthritis; THA, Total hip arthroplasty
Year: 2019 PMID: 31879489 PMCID: PMC6919379 DOI: 10.1016/j.jor.2019.08.010
Source DB: PubMed Journal: J Orthop ISSN: 0972-978X